After three years of successfully running a dedicated rounds series, the CAS Neuroanesthesia Section continues its educational efforts by hosting a neuroanesthesia webinar on February 13, 2025. Neuroanesthesia Section members and CAS members with an interest in the subspecialty can improve their knowledge on two topics:
- Sedation vs General Anesthesia for Endovascular Thrombectomy (EVT)
- Propofol – More Than an Anesthetic!?
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada and approved by the Canadian Anesthesiologists' Society. You may claim a maximum of 1 hour (credits are automatically calculated).
This webinar is moderated by CAS Neuroanesthesia Section Vice-Chair Dr Bryan Glezerson (bio).
Title: Sedation vs GA for EVT
Speaker: Dr Katija Bonin (bio)
After participating in this round, participants will be able to:
- Discuss the advantages and disadvantages of GA vs sedation for EVT
- Discuss the morbidity and mortality impact of GA vs sedation
Title: Propofol - More than an Anesthetic?
Speaker: Dr Christian Lehmann (bio)
Learning objectives:
After participating in this round, participants will be able to:
- Classify the multiple off-target effects of propofol.
- Describe the antioxidant and anti-inflammatory effects of propofol in CNS pathologies.
- Critically appraise the use of propofol in neuroanesthesia.
.png?width=200&height=206)
Moderator: Dr Bryan Glezerson
Montreal, QC
Dr. Bryan Glezerson is a neurosurgical anaesthesiologist and diagnostic
neurophysiologist at the Montréal Neurological Institute and Hospital. He completed a fellowship in neurosurgical anaesthesiology at Harvard Medical School, and a fellowship in surgical epileptology and diagnostic EEG at the Krembil Brain Institute and Toronto Western Hospital. His research interests include optimizing perioperative care for patients with drug-resistant epilepsy, and addressing tech.

Speaker: Dr Katija Bonin
Dalhousie University
Katija Bonin is a PGY-5 anesthesiology resident at Dalhousie University. She completed her undergraduate degree in Arts and Science at McMaster University and attended medical school at the University of Toronto. Katija will be pursuing a fellowship in Chronic Pain at Stanford University next year. Outside of medicine, she enjoys cooking, exploring new cuisines, and connecting with others through shared meals and experiences.

Speaker: Dr Christian Lehmann
Dalhousie University, NS
Dr Christian Lehmann is Professor of Anesthesia, Pharmacology, Microbiology & Immunology and Physiology & Biophysics at Dalhousie University, Halifax, NS, Canada. He is Staff Anesthesiologist and Medical Director of Research in the Department of Anesthesia, Pain Management and Perioperative Medicine, Nova Scotia Health Authority. Dr Lehmann has 25 years of experience in experimental and clinical inflammation and infection research. He is the author of more than 200 original publications, 5 books, and 13 book chapters. He and his collaborators received funding for their research on the therapeutic modulation of the immune response from CIHR, NSERC, CFI, MITACS, NSHRF, and Innovacorp.